WuXi XDC and HKSTP promote development of bioconjugate drug industry in Hong Kong

WuXi XDC, a China-based Contract, Research, Development, Manufacturing Organisation (CRDMO) focused on the antibody drug...

October 19, 2023 | Thursday | News
Thermo Fisher expands manufacturing facility in US for complex biologic treatments

Thermo Fisher Scientific has expanded its manufacturing capacity in St. Louis, US to support biologic therapies for dise...

October 6, 2023 | Friday | News
Lotte Biologics to establish three new bio plants in Korea by 2030

Lotte Biologics has signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) for the establ...

October 5, 2023 | Thursday | News
WuXi unveils first vaccines CDMO site in China

WuXi Vaccines, a leading contract development and manufacturing organisation (CDMO) focused on vaccine discovery, develo...

September 27, 2023 | Wednesday | News
Chinese startup Canton Biologics completes 300+ M Yuan series C financing

China-based startup Canton Biologics recently completed a Series C financing round exceeding 300 million yuan. This roun...

September 19, 2023 | Tuesday | News
Cytiva expands scientific, digital, and training offering in China

Recognising the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva ...

September 18, 2023 | Monday | News
Korea's Samsung Biologics expands oncology agreement with Bristol Myers Squibb

South Korea-based Samsung Biologics has announced a new agreement with Bristol Myers Squibb (BMS) for large-scale manufa...

September 18, 2023 | Monday | News
Europe opens largest manufacturing facility for microbiome ecosystem therapies

MaaT Pharma, a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem Therapies (ME...

September 12, 2023 | Tuesday | News
BIO Asia-Taiwan 2023: Embracing Asian Dynamics around precision health and CDMO

The Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BIO) ignited Tai...

August 31, 2023 | Thursday | Analysis
China's T-Maximum Biotech selects GenScript CRISPR reagents to target high-grade gliomas

US-based GenScript Biotech, and China-based startup T-Maximum Biotech, a biotechnology company pioneering universal...

August 10, 2023 | Thursday | News
Bora Pharmaceuticals unveils new facility in Taiwan for manufacturing ophthalmic products

Bora Pharmaceuticals, a leading contract development and manufacturing organisation (CDMO), has announced the opening of...

August 4, 2023 | Friday | News
WuXi STA launches first high potency sterile injectable manufacturing line at Wuxi City, China

WuXi STA, a global Contract Research, Development, and Manufacturing Organisation (CRDMO), has launched a first high pot...

July 21, 2023 | Friday | News
GenScript doubles manufacturing capacity with new facility in China

US-based GenScript Biotech Corporation has expanded its cGMP manufacturing capacity for single guide or sgRNA ...

July 7, 2023 | Friday | News
“APAC has one of the fastest drug discovery innovation speeds in the world”

How will the new facility benefit Singapore’s thriving pharmaceutical and biomedical ecosystem?  The Singapo...

July 4, 2023 | Tuesday | Opinion
WuXi Biologics partners with Pharmadule Morimatsu for Singapore CRDMO centre

Pharmadule Morimatsu, a subsidiary of Morimatsu International Holdings, and WuXi Biologics have officially entered ...

June 28, 2023 | Wednesday | News
Fujifilm to enhance presence in Asia for biologics and advanced therapies contract services

Fujifilm Corporation will launch a commercial office in Tokyo to provide enhanced sales support and customer servic...

June 12, 2023 | Monday | News
Korea's Samsung Biologics and Pfizer partner for long-term manufacturing of biosimilars portfolio

South Korea-based Samsung Biologics and American pharma firm Pfizer have recently announced a strategic partnership aime...

June 9, 2023 | Friday | News
China's WuXi Biologics to increase manufacturing capacity in Germany

China-headquartered WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRD...

June 2, 2023 | Friday | News